# Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2

> **NCT03666546** · PHASE4 · COMPLETED · sponsor: **Fresenius Kabi** · enrollment: 24 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Lactulose crystals 20 g
- **DRUG:** Lactulose crystals 30 g
- **DRUG:** Lactulose liquid 20 g
- **DRUG:** Lactulose liquid 30 g
- **DRUG:** Glucose
- **DRUG:** Still water

## Key facts

- **NCT ID:** NCT03666546
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-26
- **Primary completion:** 2019-03-05
- **Final completion:** 2019-03-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03666546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03666546, "Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03666546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*